# Brainsway

Brainsway is an other based in Jerusalem, Israel.

## Overview

- **Organization type:** other
- **Headquarters:** Jerusalem, Israel
- **Region:** Middle East
- **Address:** Jerusalem, Israel
- **Founded:** 2003
- **Assets under management:** Undisclosed
- **Website:** brainsway.com

## Regulatory record

- **Reports private funds:** No

## About

Mental Health is More than Meds | Axis Integrated Mental Health is an award-winning interventional psychiatry practice specializing in treating challenging depression and anxiety cases. The clinic’s board-certified mental health specialists combine modern psychiatry with

## Sectors

- Digital Health

## People

- Yaacov Michlin — President and CEO
- Abraham Zangen — Founder and Scientific Consultant

## Questions

### What clinical indications has Brainsway received FDA clearance for?

Brainsway has received FDA 510(k) clearance for three main indications: treatment-resistant major depressive disorder (MDD, 2013), obsessive-compulsive disorder (OCD, 2018), and cigarette smoking addiction (2020). The company also holds CE marking in Europe for several additional neuropsychiatric conditions. Each clearance covers the specific H-coil model and treatment protocol validated in pivotal trials.

### Who runs investment decisions at Brainsway?

Brainsway operates as a publicly traded medical device company, not an investment firm. Capital allocation decisions — including R&D spending, clinical trial funding, manufacturing expansion, and potential M&A — are made by CEO Yaacov Michlin and the executive leadership team, overseen by a board of directors chaired by David Zacut. As a commercial-stage company, Brainsway reinvests operating cash flow rather than deploying third-party investor capital.

### Does Brainsway participate in fund commitments or only direct deals?

Brainsway does not make fund commitments or direct investments as an allocator — it is an operating company that designs, manufactures, and sells medical devices. The question is misapplied; Brainsway is a Nasdaq-listed issuer, not an institutional LP. Its counterparties are hospitals, clinics, group purchasing organizations, and distributors rather than general partners or fund managers.

### What is Brainsway's known posture on co-investments alongside external GPs?

Brainsway does not have a posture on co-investments alongside GPs because it is not a capital allocator. The firm occasionally partners with academic medical centers and managed care organizations on investigator-sponsored clinical studies, which involve cost-sharing or grant funding, but these are operating partnerships rather than investment co-underwritings.

## Related profiles

- [California BanCorp](https://altss.com/profile/california-bancorp-ca)
- [Western Copper & Gold](https://altss.com/profile/western-copper-and-gold-corp)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/brainsway-ltd

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology